RevBio Receives Grant to Develop TETRANITE for Spine Fractures

RevBio announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research grant from the National Institute on Aging, part of the National Institutes of Health. This two-year grant builds upon the work that was completed in a prior Phase I grant and will enable the company to complete pre-clinical product testing,...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

PM

Patrick McGuire is an ORTHOWORLD Contributor.



Contact Us

0